Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;256(4):765-771.
doi: 10.1007/s00417-018-3899-7. Epub 2018 Jan 22.

The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries

Randolf A Widder  1   2 , Thomas S Dietlein  3 , Sven Dinslage  4 , Pia Kühnrich  5 , Corinna Rennings  5 , Gernot Rössler  5   6
Affiliations

The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries

Randolf A Widder et al. Graefes Arch Clin Exp Ophthalmol. 2018 Apr.

Abstract

Purpose: The XEN45 Gel Stent is a flexible hydrophilic tube placed under the conjunctiva via the anterior chamber. This study investigates the IOP (intraocular pressure)-lowering potential, the risk profile, and the success rate of the XEN45 Gel Stent.

Methods: Two hundred and sixty-one eyes underwent surgery. The mean follow-up time was 8.5 months. The aim of the treatment was to achieve adequate IOP reduction without medication. Therefore, all patients who did not show sufficiently reduced IOP underwent a surgical revision with opening of the conjunctiva. To determinate the success rate, we carried out two kinds of analysis: 1) the primary success rate: eyes with appropiate IOP control without medication or surgical revision, and 2) overall success rate: one surgical revision was allowed.

Results: Intraocular pressure was lowered from 24.3 mmHg (SD 6.6) to 16.8 mmHg (SD 7.6), and the medication score was lowered from 2.6 (SD 1.1) to 0.2 (SD 0.7). Revisional surgery was performed in 80 eyes (34%). After a first revision, intraocular pressure was lowered to 14.0 mmHg (SD 5.1), and the medication score was lowered to 0.2 (SD 0.6). The primary success rate was 66% and the overall success rate 90%. The primary success rate was higher in pseudophakic eyes (73%) than in phakic eyes (53%) or combined surgery (55%).

Conclusions: We conclude from our data that the XEN45 Gel Stent has an IOP-lowering potential and few side-effects. Pseudophakic eyes seem to have a better primary prognosis compared to combined surgery or surgery in phakic eyes.

Keywords: Filtering surgery; Glaucoma surgery; Migs; XEN Gel Stent.

PubMed Disclaimer

References

    1. J Cataract Refract Surg. 2015 Sep;41(9):1905-9 - PubMed
    1. J Glaucoma. 2012 Feb;21(2):71-5 - PubMed
    1. J Cataract Refract Surg. 2014 Aug;40(8):1301-6 - PubMed
    1. J Glaucoma. 2016 Jul;25(7):e691-6 - PubMed
    1. Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255 (2):359-365 - PubMed

MeSH terms

LinkOut - more resources